| Adeyemi Iyanoye, MD | |
|
368 Lakehurst Rd, Suite 301, Toms River, NJ 08755-7339 | |
| (732) 240-1048 | |
| (732) 240-3464 |
| Full Name | Adeyemi Iyanoye |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine - Cardiovascular Disease |
| Location | 368 Lakehurst Rd, Toms River, New Jersey |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1124287479 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RC0000X | Internal Medicine - Cardiovascular Disease | 25MA08587300 (New Jersey) | Primary |
| Entity Name | Meridian Medical Group-specialty Care Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1942362587 PECOS PAC ID: 6507962206 Enrollment ID: O20070425000673 |
News Archive
Autumn brings tales of scary delight but none terrifies parents so much as the note home from school that a case of lice has been detected.
In response to a recent New York Times article that questions why currently available medications designed to treat and prevent some cancers are being ignored, ECRI Institute, an independent nonprofit organization, is offering a roadmap to the evidence on Finasteride for Prevention of Prostate Cancer for free download.
According to MassDevice.com, the online business journal of the medical device industry, medical device approval times under the Food & Drug Administration's 510(k) clearance process jumped 30 percent between 2005 and 2008. MassDevice's exclusive investigation of 10 years of FDA data, Eye on the FDA: H1 2009, shows that approval times for medical devices increased nearly 2 percent — while the number of 510(k) applications declined more than 19 percent — even as the FDA's budgets and staff levels rose.
Dominion Diagnostics (Dominion) has recently developed and validated one of the first clinical quantitative assays for the drug tapentadol (Nucynta(TM)) performed by liquid chromatography/tandem mass spectrometry (LC/MS/MS). Tapentadol, recently approved for use by the FDA, is a centrally-active analgesic that has demonstrated efficacy in pain relief with improved gastrointestinal tolerability compared to other opioids for pain management.
› Verified 2 days ago
| Entity Name | Rb Cardiology Reading Associates Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1285969063 PECOS PAC ID: 7113062746 Enrollment ID: O20100306000028 |
News Archive
Autumn brings tales of scary delight but none terrifies parents so much as the note home from school that a case of lice has been detected.
In response to a recent New York Times article that questions why currently available medications designed to treat and prevent some cancers are being ignored, ECRI Institute, an independent nonprofit organization, is offering a roadmap to the evidence on Finasteride for Prevention of Prostate Cancer for free download.
According to MassDevice.com, the online business journal of the medical device industry, medical device approval times under the Food & Drug Administration's 510(k) clearance process jumped 30 percent between 2005 and 2008. MassDevice's exclusive investigation of 10 years of FDA data, Eye on the FDA: H1 2009, shows that approval times for medical devices increased nearly 2 percent — while the number of 510(k) applications declined more than 19 percent — even as the FDA's budgets and staff levels rose.
Dominion Diagnostics (Dominion) has recently developed and validated one of the first clinical quantitative assays for the drug tapentadol (Nucynta(TM)) performed by liquid chromatography/tandem mass spectrometry (LC/MS/MS). Tapentadol, recently approved for use by the FDA, is a centrally-active analgesic that has demonstrated efficacy in pain relief with improved gastrointestinal tolerability compared to other opioids for pain management.
› Verified 2 days ago
| Entity Name | The Younan Group Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1023757978 PECOS PAC ID: 9436537909 Enrollment ID: O20220908001001 |
News Archive
Autumn brings tales of scary delight but none terrifies parents so much as the note home from school that a case of lice has been detected.
In response to a recent New York Times article that questions why currently available medications designed to treat and prevent some cancers are being ignored, ECRI Institute, an independent nonprofit organization, is offering a roadmap to the evidence on Finasteride for Prevention of Prostate Cancer for free download.
According to MassDevice.com, the online business journal of the medical device industry, medical device approval times under the Food & Drug Administration's 510(k) clearance process jumped 30 percent between 2005 and 2008. MassDevice's exclusive investigation of 10 years of FDA data, Eye on the FDA: H1 2009, shows that approval times for medical devices increased nearly 2 percent — while the number of 510(k) applications declined more than 19 percent — even as the FDA's budgets and staff levels rose.
Dominion Diagnostics (Dominion) has recently developed and validated one of the first clinical quantitative assays for the drug tapentadol (Nucynta(TM)) performed by liquid chromatography/tandem mass spectrometry (LC/MS/MS). Tapentadol, recently approved for use by the FDA, is a centrally-active analgesic that has demonstrated efficacy in pain relief with improved gastrointestinal tolerability compared to other opioids for pain management.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Adeyemi Iyanoye, MD 368 Lakehurst Rd, Suite 301, Toms River, NJ 08755-7339 Ph: (732) 240-1048 | Adeyemi Iyanoye, MD 368 Lakehurst Rd, Suite 301, Toms River, NJ 08755-7339 Ph: (732) 240-1048 |
News Archive
Autumn brings tales of scary delight but none terrifies parents so much as the note home from school that a case of lice has been detected.
In response to a recent New York Times article that questions why currently available medications designed to treat and prevent some cancers are being ignored, ECRI Institute, an independent nonprofit organization, is offering a roadmap to the evidence on Finasteride for Prevention of Prostate Cancer for free download.
According to MassDevice.com, the online business journal of the medical device industry, medical device approval times under the Food & Drug Administration's 510(k) clearance process jumped 30 percent between 2005 and 2008. MassDevice's exclusive investigation of 10 years of FDA data, Eye on the FDA: H1 2009, shows that approval times for medical devices increased nearly 2 percent — while the number of 510(k) applications declined more than 19 percent — even as the FDA's budgets and staff levels rose.
Dominion Diagnostics (Dominion) has recently developed and validated one of the first clinical quantitative assays for the drug tapentadol (Nucynta(TM)) performed by liquid chromatography/tandem mass spectrometry (LC/MS/MS). Tapentadol, recently approved for use by the FDA, is a centrally-active analgesic that has demonstrated efficacy in pain relief with improved gastrointestinal tolerability compared to other opioids for pain management.
› Verified 2 days ago
Dr. Vanie S Ramachandra Rao, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 14 Hospital Dr, Toms River, NJ 08755 Phone: 732-244-3100 | |
Dr. Gregory J Cuozzo, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 102 Commons Way, Toms River, NJ 08755 Phone: 732-349-4434 Fax: 732-349-9290 | |
Dr. Prabhat Kumar Sinha, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 20 Hospital Dr, Ste 3, Toms River, NJ 08755 Phone: 732-341-9900 Fax: 732-341-9968 | |
Dr. Satish K Bhutani, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1416 Hooper Ave, Toms River, NJ 08753 Phone: 848-223-7120 Fax: 732-349-6919 | |
Rajat K Dhar, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 442d Commons Way, Toms River, NJ 08755 Phone: 732-505-3510 Fax: 732-505-5308 | |
Dr. Joseph Anthony Decorso Jr., MD Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 20 Montreal Ct, Toms River, NJ 08757 Phone: 973-699-1830 | |
Dr. Martin Zaratan Jimenez, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 25 Mule Rd, Building A, Toms River, NJ 08755 Phone: 732-240-0404 Fax: 732-244-3555 |